William Drobyski is an Oncology physician affiliated with Medical College of Wisconsin. OpenAlex indexes 251 publications with 10,673 citations (h-index 52); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9200 W Wisconsin Ave
Bone Marrow Transplant
Milwaukee, WI 532263522
Telephone
414-805-6817Provider last certified this registry record 19 Aug 2022.
Clinical trials
- Tildrakizumab for Prevention of Acute Graft-Versus-Host Disease
Sponsor: Medical College of Wisconsin
- PROACTIVE: Preventing Acute/Chronic GVHD With TocIlizumab Combined With GVHD Prophylaxis Post allogEneic Transplant
Sponsor: Medical College of Wisconsin
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
NIH funding
11 NIH research awards on record, funded 1991–2026 per NIH RePORTER. The latest:
- Augmenting Regulatory T Cell Reconstitution during GVHD
Medical College of Wisconsin
FY2026$675,405R01HL179210 - Inflammatory Cytokine Networks in Gastrointestinal Tract Graft Versus Host Disease
Medical College of Wisconsin
FY2026$595,963R01HL126166 - Inflammatory Cytokine Networks in Gastrointestinal Tract Graft Versus Host Disease
Medical College of Wisconsin
FY2025$608,125R01HL126166
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The IL-6 antagonist tocilizumab is associated with worse depression and related symptoms in the medically ill
Translational Psychiatry
2021 - Efficacy, Toxicity, and Infectious Complications in Ruxolitinib-Treated Patients with Corticosteroid-Refractory Graft-versus-Host Disease after Hematopoietic Cell Transplantation
Biology of Blood and Marrow Transplantation
2019 - <scp>L</scp>oss of <scp>FFAR</scp>2 promotes colon cancer by epigenetic dysregulation of inflammation suppressors
International Journal of Cancer
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Razelle Kurzrock, MD
Medical College of Wisconsin
Mary Horowitz, MD
Medical College of Wisconsin
Janet Rader, MD
Medical College of Wisconsin
Bruce Camitta, MD
Medical College of Wisconsin
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”